| Record ID | marc_loc_2016/BooksAll.2016.part17.utf8:159475807:988 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part17.utf8:159475807:988?format=raw |
LEADER: 00988nam a2200265 a 4500
001 86211078
003 DLC
005 19900425140851.3
008 861003c19851986onca b f00010 eng
010 $a 86211078
020 $a0662144996 (pbk.)
040 $aDLC$cDLC$dDLC
043 $an-cn---
050 00 $aKE3714.A72$bG69 1986
082 00 $a344.71/04233$a347.1044233$220
100 10 $aGoyer, Robert.
245 10 $aRegulatory aspects and their influence on pharmaceutical research and on the introduction of drugs in Canada /$cRobert Goyer.
260 0 $a[Toronto] :$bCommission of Inquiry on the Pharmaceutical Industry,$c[1985], c1986.
300 $a[3], 170, [25] p. :$bill. ;$c28 cm.
500 $a"February 1985."
500 $a"Background study"--Cover.
504 $aBibliography: p. 1-3 (1st group).
650 0 $aDrugs$xTesting$xLaw and legislation$zCanada.
650 0 $aPharmaceutical industry$zCanada.
710 10 $aCanada.$bCommission of Inquiry on the Pharmaceutical Industry.